Hepatitis C Virus Elimination Using Direct Acting Antivirals after the Radical Cure of Hepatocellular Carcinoma Suppresses the Recurrence of the Cancer

SIMPLE SUMMARY: In patients with hepatitis C virus-related liver disease, direct-acting antivirals (DAAs) suppress the development of hepatocellular carcinoma (HCC). However, it is unclear whether their use after curative HCC treatment suppresses its recurrence in patients with hepatitis C virus-rel...

Descripción completa

Detalles Bibliográficos
Autores principales: Kuromatsu, Ryoko, Ide, Tatsuya, Okamura, Shusuke, Noda, Yu, Kamachi, Naoki, Nakano, Masahito, Shirono, Tomotake, Shimose, Shigeo, Iwamoto, Hideki, Kuwahara, Reiichiro, Arinaga-Hino, Teruko, Niizeki, Takashi, Zaizen, Yuki, Takaki, Hiroshi, Shirachi, Miki, Koga, Hironori, Torimura, Takuji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9103530/
https://www.ncbi.nlm.nih.gov/pubmed/35565424
http://dx.doi.org/10.3390/cancers14092295

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9103530/
https://www.ncbi.nlm.nih.gov/pubmed/35565424
http://dx.doi.org/10.3390/cancers14092295

Ejemplares similares